Evidence map›Paper›PMID 40574825›Full record

ArticleFrontiers in bioengineering and biotechnology2025

Tunable methacrylated decellularized heart matrix: a versatile scaffold for cardiac tissue engineering.

Valinteshley Pierre, Douglas H Wu, Chao Liu, Elif Ertugral, Chandrasekhar Kothapalli, Samuel E Senyo

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Valinteshley PierreDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, United States.
Douglas H WuDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, United States.
Chao LiuDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, United States.
Elif ErtugralDepartment of Chemical and Biomedical Engineering, Cleveland State University, Cleveland, OH, United States.
Chandrasekhar KothapalliDepartment of Chemical and Biomedical Engineering, Cleveland State University, Cleveland, OH, United States.
Samuel E SenyoDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, United States.

Funding

Mechanistic tRNA modification affects to agingR21AG091047 · NIA · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI PRESTWICH, ERIN G, SENYO, SAMUEL · 2025 to 2025
$431k
NIA NIH HHS R21 AG091047
6 · The paper itself

Abstract

Therapeutic tissue regeneration remains a significant unmet need in heart failure and cardiovascular disease treatment, which are among the leading causes of death globally. Decellularized heart matrix (DHM) offer promising advantages for tissue engineering, including low immunogenicity and seamless integration into biological processes, facilitating biocompatibility. However, DHM is challenged by weak mechanical properties that limit its utility to biomedical applications like tissue engineering. To address this limitation, we functionalized DHM with methacryloyl functional groups (DHMMA) that support UV-induced crosslinking to enhance mechanical properties. By modulating the degree of methacryloyl substitution, a broad range of stiffness was achieved while maintaining cell viability on crosslinked DHMMA. Additionally, we show that increasing UV exposure time and pH increases DHMMA stiffness. Furthermore, topographical features transferred on DHMMA via soft lithography facilitated physical orientation of cells in culture. We demonstrate DHMMA as a scaffold with tunable stiffness and matrix-degradation properties suitable for cell survival and microfabrication for cardiac tissue engineering applications.

Indexed as

biomaterialsdecellularized heart matrixmatrix protein releasemethacrylationultra-violet crosslinking

Identifiers

PMID40574825
PMCPMC12198208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.